Clinical trial

Carillon Mitral Contour System® for Reducing Functional Mitral Regurgitation

NCT02325830 · Cardiac Dimensions Pty Ltd, Industry · Completed

Key facts

NCT number NCT02325830
Title Carillon Mitral Contour System® for Reducing Functional Mitral Regurgitation
Official title The REDUCE FMR Trial: Safety and Efficacy of the Carillon Mitral Contour System® in Reducing Functional Mitral Regurgitation (FMR) Associated With Heart Failure
Acronym REDUCE FMR
Lead sponsor Cardiac Dimensions Pty Ltd, Industry
Collaborators Menzies Institute for Medical Research
Status Completed
Study type Interventional
Conditions Mitral Valve Insufficiency, Heart Failure
Intervention type Device
Interventions Carillon Mitral Contour System
Enrollment 163
Start date Aug 22, 2015
Primary completion Jul 1, 2018
Completion Jan 8, 2020
First posted Dec 25, 2014
Last update posted Aug 5, 2024
Countries Australia, Czechia, France, Germany, Netherlands, New Zealand, Poland, United Kingdom

At a glance

  • 10–99 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies